| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |